Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03367767 · ClinicalTrials.gov registry record
Age-Related Eye Disease Study 2 (AREDS2) 10-year Follow-On
A clinical trial, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- 709
- Enrollment target
NCT03367767 is a clinical trial that has completed, run by National Eye Institute (NEI). The registered enrollment target is 709 participants.
The verdict
NCT03367767 has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- 709 participants
- Enrollment target
Study Summary
Background: Age-related macular degeneration (AMD) and cataracts are two eye diseases. They were studied in the Age-Related Eye Disease Study (AREDS2) and the AREDS2 Follow-On study. These studies followed the natural course of the diseases. They also provided data on the long-term effects of certain oral supplements on AMD. Objective: To study the long-term effects of oral supplements on several things. These include incidences of lung cancer, development of late AMD, cataract surgery, cognitive function, and cardiovascular events. Eligibility: Former AREDS2 and AREDS2 Follow-On participants Design: Participants will have 1 visit. It will include: An eye exam that tests how well participants can see, measures eye pressure, and checks eye movements. The pupil will be dilated with eye drops. Pictures will be taken of the retina and the inside of the eye. Participants will grip a device in their hand to measure their grip strength. A blood sample will be taken. This will be stored for future genetic research. Cells may be created from the sample. A small sample of skin will be taken. Sponsoring Institution: National Eye Institute
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 709 participants |
| Start Date | 2018-05-23 |
| Est. Completion | 2019-03-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03367767
The ClinicalTrials.gov registry entry for NCT03367767 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 709 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03367767 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03367767 about?
NCT03367767 is a clinical study titled "Age-Related Eye Disease Study 2 (AREDS2) 10-year Follow-On". Background: Age-related macular degeneration (AMD) and cataracts are two eye diseases. They were studied in the Age-Related Eye Disease Study (AREDS2) and the AREDS2 Follow-On study. These studies followed the natural course of the diseases. They also provided data on the long-term effects of certa...
What is the current status of trial NCT03367767?
This trial is currently completed. The enrollment target is 709 participants. The study started on 2018-05-23. Estimated completion is 2019-03-21.
Who is sponsoring clinical trial NCT03367767?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.